ArticleJournal of hematology & oncology2018

Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.

Ying Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.